Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Food advisory committee meeting

This article was originally published in The Tan Sheet

Executive Summary

Proposed osteoarthritis health claims for glucosamine & chondroitin sulfate, as well as crystalline glucosamine sulfate are the topic of the next meeting of CFSAN's Food Advisory Committee, scheduled for June 7 and 8. A portion of the meeting involving the Dietary Supplement Subcommittee will gather information and advice related to the etiology of osteoarthritis and the relevance of scientific studies cited in the petitions. The meeting will be held at the Bethesda Marriott, 5150 Pooks Hill Road. Weider filed a petition with FDA in mid-2003 seeking a qualified health claim to link products containing glucosamine and/or chondroitin sulfate with a reduced risk of osetoarthritis (1"The Tan Sheet" June 16, 2003, p. 17)...
Advertisement

Related Content

Chondroitin/Glucosamine Osteoarthritis Risk Reduction Claim Requested
Chondroitin/Glucosamine Osteoarthritis Risk Reduction Claim Requested

Topics

Advertisement
UsernamePublicRestriction

Register

PS096804

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel